Abstract
Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).
| Original language | English |
|---|---|
| Pages (from-to) | 803-807 |
| Number of pages | 5 |
| Journal | European Journal of Ophthalmology |
| Volume | 24 |
| DOIs | |
| Publication status | Published - 2014 |
Keywords
- Acute Disease
- Adult
- Coloring Agents
- Dexamethasone
- Drug Implants
- Exudates and Transudates
- Fluorescein Angiography
- Glucocorticoids
- Humans
- Indocyanine Green
- Male
- Tomography, Optical Coherence
- Visual Acuity
- Vitelliform Macular Dystrophy
- Vitreous Body
Fingerprint
Dive into the research topics of 'Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver